Responding to COVID-19: A Science-Based Approach

Brought to you by the American Public Health Association and the National Academy of Medicine, this webinar series is exploring the state of the science surrounding the current outbreak of COVID-19 in the United States and globally, with a focus on the emerging evidence on how to best mitigate its impact. Hear from trusted experts in such fields as public health, infectious disease, risk communication, and crisis standards of care.

Webinar #15: COVID-19 Vaccine Update — Development, Approval, Allocation and Distribution in the U.S.
Wednesday, Nov. 18, 5-6:30 p.m. (ET)

Peggy Hamburg James Hildreth Larry Corey Marion Gruber Jay Butler

The 15th COVID-19 Conversations webinar discussed the path to a COVID-19 vaccine, including steps forward in development, approval and allocation.

Our expert panel:

  • Peggy Hamburg, MD (Moderator) — Former FDA commissioner
  • James Hildreth, PhD, MD — President and CEO, Meharry Medical College
  • Larry Corey, MD — President and Director, Fred Hutch
  • Marion Gruber, PhD — Director, Office of Vaccine Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration
  • Jay Butler, MD — Deputy Director for Infectious Diseases, Centers for Disease Control and Prevention 

Webinar # 14: Until We Have a Vaccine — Surveillance, Testing and Contact Tracing

Karen DeSalvo Martin Burke  LaQuandra Nesbitt Michael Osterholm

The 14th COVID-19 Conversations webinar discussed the many aspects of COVID-19 containment, including best practices for disease surveillance and outbreak identification, testing strategies and opportunities, and progress on contact tracing.

Our expert panel:

  • Karen DeSalvo (Moderator) — Chief Health Officer, Google
  • Martin Burke — May and Ving Lee Professor for Chemical Innovation, University of Illinois
  • LaQuandra Nesbitt — Director, District of Columbia Department of Health
  • Michael Osterholm — Director, Center for Infectious Disease Research and Policy, University of Minnesota 



The webinar series draws from and complements existing advisory activities underway at APHA and the National Academies, including the Standing Committee on Emerging Infectious Diseases and 21st Century Health Threats, which was convened for the purpose of advising the White House and federal agencies on the U.S. response to COVID-19.

The series rapidly and regularly provides trustworthy scientific analysis of the latest COVID-19 developments for the benefit of policymakers, public health and health care officials, and the general public.

The series is exploring the scientific basis for guidance issued by government, health and public health organizations, and industry, as well as answering questions that are top of mind for its audiences.

Questions? Contact us.

Stay in the know


Questions? Need Help?